Identification | Back Directory | [Name]
TFLLR-NH2(TFA) | [CAS]
1313730-19-6 | [Synonyms]
TFLLR-NH2(TFA) 197794-83-5 (Thr1)-TRAP-5 amide | [Molecular Formula]
C33H54F3N9O8 | [MDL Number]
MFCD05663482 | [MOL File]
1313730-19-6.mol | [Molecular Weight]
761.85 |
Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
Water: 100 mg/mL (131.26 mM); DMSO: 100 mg/mL (131.26 mM) | [form ]
Solid | [color ]
White to off-white | [Sequence]
H-Thr-Phe-Leu-Leu-Arg-NH2 |
Hazard Information | Back Directory | [Biological Activity]
TFLLR-NH2 (TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM. | [in vitro]
PAR1 agonists stimulate concentration-dependent increases in [Ca 2+ ]i and in the proportions of neurones. The maximal increase in [Ca 2+ ] i above basal is detected in response to 10 μm TF-NH2 (peak 196.5±20.4 nM, n=25) when 50–80% of identified neurones responded. SW620 cells cultured in the supernatant of TFLLR-NH2-activated platelets upregulate E- cadherin expression and downregulate the vimentin expression. In the in vitro platelet culture system, a TFLLR-NH2 dose-dependent increase of secreted TGF-β1 is detected in the supernatant. < b> | [in vivo]
Injection of TF-NH2 into the rat paw stimulates a marked and sustained oedema. An NK1R antagonist and ablation of sensory nerves with capsaicin inhibit oedema by 44% at 1 h and completely by 5 h. In wild-type but not PAR1 ?/? mice, TF-NH2 stimulates Evans blue extravasation in the bladder, oesophagus, stomach, intestine and pancreas by 2–8 fold. Extravasation in the bladder, oesophagus and stomach is abolished by an NK1R antagonist. TFp-NH2 produces notable contraction at 3-50 μM and relaxation at 0.3-50 μM, in the absence of apamin. The concentration-response curve for TFp-NH2-induced contraction is remarkably shifted left, when the TFp- NH2-induced relaxation is blocked by apamin at 0.1 μM. | [target]
|
|
|